Current Affairs
Daily Bits

BARC develops Eye Cancer therapy

  • Posted By
  • Categories
    Science & Technology
  • Published
    2nd Jan, 2021

Bhabha Atomic Research Centre (BARC) Mumbai has developed Eye Cancer therapy in the form of the first indigenous Ruthenium 106 Plaque for treatment of Ocular Tumours.


  • The handling of plaque is very convenient for the Surgeon and it has been acknowledged to be at par with the international standards.
  • So far, the BARC plaques made in India through the Department of Atomic Energy have been used for seven cases for Ocular Cancer:
    • 2- Retinoblastoma
    • 2- Choroidal Melanoma
    • 2- Ocular Surface Squamous Neoplasia (OSSN)
    • 1- case of Choroidal Hemangioma

Ocular Tumors

  • Ocular tumors are tumors inside the eye.
  • They are collections of cells that grow and multiply abnormally and form masses.
  • They can be benign or malignant. In adults the most common type is metastatic, from another part of the body (lung, breast, prostate, etc).

What is ruthenium-106?

  • Ruthenium-106 is a radioactive form of the rare heavy metal ruthenium, which is a "platinum group" metal similar to platinum.
  • Radioactive isotopes or forms of elements naturally decay into other elements, giving off radiation in the process.
  • Ruthenium-106 is produced from the fission or splitting of uranium-235, the type of uranium used in nuclear fission reactors, so it's found in spent nuclear fuel. 

Verifying, please be patient.